Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 8, 2004. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions and does not contain financial performance data.
Material Changes
The only material change reported is a transaction involving the GlaxoSmithKline Employee Trust ("GSK Trust"). On July 7, 2004, the trust transferred 4,342 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. The company was advised of this transaction on October 8, 2004.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. It strictly details the share transfer and notes that three directors (Dr J-P Garnier, Dr T Yamada, and Mr J D Coombe) hold interests in the GSK Trust as potential beneficiaries alongside other employees.
Key Facts for Investor Verification
- 4,342 Ordinary Shares were transferred from the GSK Trust to employee plan participants.
- Three directors have indirect interests in the shares held by the GSK Trust.
- No financial performance metrics are disclosed in this specific filing.